Clinical Trial

An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.
Protocol Amendment History 4 changes
critical Recruitment opened 2026-06-13
notable Trial sites expanded: 0 -> 4 locations 2026-06-05
notable Primary completion pushed: 2029-05 -> 2029-06 2026-06-05
minor Completion pushed: 2029-05 -> 2029-06 2026-06-05
Trial Details
NCT Number NCT07583563
Lead Sponsor Camurus AB
Conditions Acromegaly
Enrollment 200 participants
Start Date 2026-06-05
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-12